Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptorsQing Fan, Don C. Wiley, Lidia Mosyak et al.|Nature|1997Cited by 165
<i>In vivo</i> tumor cell rejection induced by NK cell inhibitory receptor blockade: Maintained tolerance to normal cells even in the presence of IL‐2Gustaf Vahlne, Maria H. Johansson, Tadepally Lakshmikanth et al.|European Journal of Immunology|2009Cited by 35
962 A novel alpha-active IL-2-Fc has expanded therapeutic index and robust monotherapy efficacy in mouse cancer models and strong synergy with PD-1 blockadeAdam Stockmann, Ann Cheung, S.R. Vincent et al.|Regular and Young Investigator Award Abstracts|2024Cited by 0
DF6215, an α-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activityAdam Stockmann, Ann Cheung, Sylvia Vincent et al.|Cell Reports Medicine|2025Cited by 0